E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL
Tian, Jianjun, Lin, Yuting, Yu, JianhuaVolume:
92
Language:
english
Journal:
Biomedicine & Pharmacotherapy
DOI:
10.1016/j.biopha.2017.05.118
Date:
August, 2017
File:
PDF, 2.63 MB
english, 2017